79
Views
6
CrossRef citations to date
0
Altmetric
Review

Complete androgen insensitivity syndrome: diagnosis and management

, , , , , & show all
Pages 565-573 | Published online: 10 Jan 2014

References

  • Morris JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am. J. Obstet. Gynecol.65, 1192–1211 (1953).
  • Ahmed SF, Cheng A, Dovey L et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J. Clin. Endocrinol. Metab.85(2), 658–665 (2000).
  • Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J. Clin. Endocrinol. Metab.85(8), 2664–2669 (2000).
  • Boehmer AL, Brinkmann O, Brüggenwirth H et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J. Clin. Endocrinol. Metab.86(9), 4151–4160 (2001).
  • Melo KF, Mendonca BB, Billerbeck AE et al. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J. Clin. Endocrinol. Metab.88(7), 3241–3250 (2003).
  • Cheikhelard A, Morel Y, Thibaud E et al. Long-term follow-up and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J. Urol.180(4), 496–501 (2008).
  • Purves JT, Miles-Thomas J, Migeon C, Gearhart JP. Complete androgen insensitivity: the role of the surgeon. J. Urol.180(4 Suppl.), 1716–1719 (2008).
  • Minto CL, Liao KL, Conway GS et al. Sexual function in women with complete androgen insensitivity syndrome. Fertil. Steril.80(1), 157–164 (2003).
  • Hines M, Ahmed SF, Hughes IA. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch. Sex. Behav.32(2), 93–101 (2003).
  • Deeb A, Hughes IA. Inguinal hernia in female infants: a cue to check the sex chromosomes? BJU Int.96(3), 401–403 (2005).
  • Gottlieb B, Beitel LK, Wu JH, Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat.23(6), 527–533 (2004).
  • Sobel V, Schwartz B, Zhu YS et al. Bone mineral density in the complete androgen insensitivity and 5α-reductase-2 deficiency syndromes. J. Clin. Endocrinol. Metab.91(8), 3017–3023 (2006).
  • Conn J, Gillam L, Conway GS. Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ331(7517), 628–630 (2005).
  • Lee PA, Houk CP, Ahmed SF et al. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Pediatrics118(2), e488–e500 (2006).
  • Baksu A, Kabukcuoglu F, Baksu B et al. Bilateral sertoli cell adenoma and serous cyst in a patient with androgen insensitivity syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol.114(1), 104–107 (2004).
  • Hughes IA, Deeb A. Androgen resistance. Best. Pract. Res. Clin. Endocrinol. Metab.20(4), 577–598 (2006).
  • Galani A, Kitsiou-Tzeli S, Sofokleous C et al. Androgen insensitivity syndrome: clinical features and molecular defects. Hormones (Athens)7(3), 217–29 (2008).
  • Hannema SE, Scott IS, Rajpert-De Meyts E et al., Testicular development in the complete androgen insensitivity syndrome. J. Pathol.208(4), 518–527 (2006).
  • Sarpel U, Palmer SK, Dolgin SE. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J. Pediatr. Surg.40(1), 133–136, discussion 136–137 (2005).
  • Hurme T, Lahdes-Vasama T, Makela E et al. Clinical findings in prepubertal girls with inguinal hernia with special reference to the diagnosis of androgen insensitivity syndrome. Scand. J. Urol. Nephrol.43(1), 42–46 (2009).
  • Bouvattier C, Carel JC, Lecointre C et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J. Clin. Endocrinol. Metab.87(1), 29–32 (2002).
  • Papadimitriou DT, Linglart A, Morel Y et al. Puberty in subjects with complete androgen insensitivity syndrome. Horm. Res.65(3), 126–131 (2006).
  • Jorgensen PB, Kjartansdóttir KR, Fedder J. Care of women with XY karyotype: a clinical practice guideline. Fertil. Steril. (2009) (Epub ahead of print).
  • Boukari K, Meduri G, Brailly-Tabard S et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J. Clin. Endocrinol. Metab.94(5), 1818–1825 (2009).
  • Hannema SE, Scott IS, Hodapp J et al. Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. J. Clin. Endocrinol. Metab.89(11), 5815–5822 (2004).
  • Barbaro M, Oscarson M, Almskog I et al. Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development. Clin. Endocrinol. (Oxf.)66(6), 822–826 (2007).
  • Cools M, van Aerde K, Kersemaekers AM et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J. Clin. Endocrinol. Metab.90(9), 5295–5303 (2005).
  • Cheng L, Sung MT, Cossu-Rocca P et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol.211(1), 1–9 (2007).
  • Looijenga LH, Hersmus R, Oosterhuis JW et al. Tumor risk in disorders of sex development (DSD). Best Pract. Res. Clin. Endocrinol. Metab.21(3), 480–495 (2007).
  • Köhler B, Lumbroso S, Leger J et al. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J. Clin. Endocrinol. Metab.90(1), 106–111 (2005).
  • Nichols JL, Bieber EJ, Gell JS. Case of sisters with complete androgen insensitivity syndrome and discordant Müllerian remnants. Fertil. Steril.91(3), 932.e.15–932.e.18 (2009).
  • Quigley CA, Friedman KJ, Johnson A. Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. Clin. Endocrinol. Metab.74(4), 927–933 (1992).
  • Han TS, Goswami D, Trikudanathan S et al. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur. J. Endocrinol.159(2), 179–185 (2008).
  • Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med. Pediatr. Oncol.41(3), 217–221 (2003).
  • Taes Y, Lapauw B, Vandewalle S et al. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity. Bone45(2), 392–397 (2009).
  • Hindmarsh PC. How do you initiate oestrogen therapy in a girl that has not undergone puberty? Clin. Endocrinol. (Oxf.)71(1), 7–10 (2009).
  • Bertelloni S, Dati E, Baroncelli GI. Disorders of sex development: hormonal management in adolescence. Gynecol. Endocrinol.24(6), 339–46 (2008).
  • DiVasta AD, Gordon CM. Hormone replacement therapy for the adolescent patient. Ann. NY Acad. Sci.1135, 204–211(2008).
  • Cools M, Drop SL, Wolffenbuttel KP et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr. Rev.27(5), 468–484 (2006).
  • Iwamoto I, Yanazume S, Fujino T et al. Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome. Gynecol. Oncol.96(3), 870–872 (2005).
  • Talerman A, Roth LM. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives. Int. J. Gynecol. Pathol.26(3), 313–321 (2007).
  • Horcher E, Grünberger W, Parschalk O. Classical seminoma in a case of testicular feminization syndrome. Prog. Pediatr. Surg.16, 139–141 (1983).
  • Hurt WG, Bodurtha JN, McCall JB et al. Seminoma in pubertal patient with androgen insensitivity syndrome. Am. J. Obstet. Gynecol.161(3), 530–531 (1989).
  • Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int. J. Gynecol. Pathol.10(2), 126–144 (1991).
  • Lloyd J, Crouch NS, Minto CL et al. Female genital appearance: ‘normality’ unfolds. BJOG112(5), 643–646 (2005).
  • Ismail-Pratt IS, Bikoo M, Liao LM et al. Normalization of the vagina by dilator treatment alone in complete androgen insensitivity syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. Hum. Reprod.22(7), 2020–2024 (2007).
  • Mazur T. Gender dysphoria and gender change in androgen insensitivity or micropenis. Arch. Sex. Behav.34(4), 411–421 (2005).
  • Reiner WG. Gender identity and sex-of-rearing in children with disorders of sexual differentiation. J. Pediatr. Endocrinol. Metab.18(6), 549–553 (2005).
  • Danilovic DL, Correa PH, Costa EM et al. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos. Int.18(3), 369–374 (2007).
  • Vanderschueren D, Vandenput L, Boonen S et al. Androgens and bone. Endocr. Rev.25(3), 389–425 (2004).
  • Salmasi AH, Wisniewski AB, Novak TE et al. Prostate screening in patients with 46,XY disorders of sex development – is it necessary? J. Urol.180(4), 1422–1425 (2008).
  • Robboy SJ, Jaubert F. Neoplasms and pathology of sexual developmental disorders (intersex). Pathology39(1), 147–163 (2007).
  • Kerkhofs S, Denayer S, Haelens A et al. Androgen receptor knockout and knock-in mouse models. J. Mol. Endocrinol.42(1), 11–17 (2009).
  • Berg JS, French SL, McCullough LB et al. Ethical and legal implications of genetic testing in androgen insensitivity syndrome. J. Pediatr.150(4), 434–438 (2007).
  • Quigley CA, De Bellis A, Marschke KB et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev.16(3), 271–321 (1995).
  • Werner R, Zhan J, Gesing J et al.In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits. Sex. Dev.2(2), 73–83 (2008).
  • Davies MC, Creighton SM, Woodhouse CR. The pitfalls of vaginal construction. BJU Int.95(9), 1293–1298 (2005).
  • Burgu B, Duffy PG, Cuckow P et al. Long-term outcome of vaginal reconstruction: comparing techniques and timing. J. Pediatr. Urol.3(4), 316–320 (2007).
  • Johannsen TH, Ripa CP, Mortensen EL et al. Quality of life in 70 women with disorders of sex development. Eur. J. Endocrinol.155(6), 877–885 (2006).
  • Oakes MB, Eyvazzadeh AD, Quint E et al. Complete androgen insensitivity syndrome – a review. J. Pediatr. Adolesc. Gynecol.21(6), 305–10 (2008).
  • Heller-Boersma JG, Schmidt UH, Edmonds DK. A randomized controlled trial of a cognitive-behavioural group intervention versus waiting-list control for women with uterovaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome: MRKH). Hum. Reprod.22(8), 2296–301(2007).
  • Heller-Boersma JG, Edmonds DK, Schmidt UH. A cognitive behavioural model and therapy for utero-vaginal agenesis (Mayer–Rokitansky–Küster–Hauser syndrome: MRKH). Behav. Cogn. Psychother.37(4), 449–467 (2009).
  • Bilezikian JP. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. Am. J. Med.122(2 Suppl.), S14–S21 (2009).
  • Dennis C. Brain development: the most important sexual organ. Nature427(6973), 390–392 (2004).
  • Arnold AP, Xu J, Grisham W et al. Minireview: Sex chromosomes and brain sexual differentiation. Endocrinology145(3), 1057–1062 (2004).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.